Form D · Biotechnology
TELA Bio, Inc.
Malvern, PA · CIK 0001561921
Offering snapshot reported Jul 10, 2019 · SEC filing
- Reported sold
- $10.6M Offering amount: $20M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2019 | Initial | $10,623,181 | No comparison | 15 | SEC filing |
| Dec 4, 2018 | Initial | $2,067,080 | No comparison | 8 | SEC filing |
| May 14, 2018 | Initial | $501,120 | No comparison | 1 | SEC filing |
| May 4, 2018 | Initial | $240,000 | No comparison | 1 | SEC filing |
| Apr 20, 2018 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Apr 2, 2018 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Nov 2, 2017 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Jan 27, 2017 | Initial | $7,386,295 | No comparison | 16 | SEC filing |
| Nov 24, 2014 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Oct 8, 2014 | Initial | $45,370,140 | No comparison | 29 | SEC filing |
| Aug 14, 2013 | Initial | $6,000,000 | No comparison | 16 | SEC filing |
| Dec 6, 2012 | Initial | $16,152,500 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-343859
Source: Form D, filed Jul 10, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kurt Ararbarzin | Director |
| Christine Arasin | Executive |
| Kurt Azarbarzin | Director |
| Nora Brennan | Executive |
| Vince Burgass | Director |
| Vince Burgess | Director |
| Francis Conway | Executive |
| Ronald J. Ellis Jr. | Director |
| Ronald J. Ellis, Jr. | Director |
| Ashley Freidman | Director |
| Ashley Friedman | Director |
| Antony Koblish | Director, Executive |
| Adele Oliva | Director |
| Maarten Persenaire | Executive |
| Kevin Rakin | Director |
| Christoper Smith | Executive |
| Christopher Smith | Executive |
| Paul Touhey | Director |
| Matt Zuga | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Great Valley Parkway, Suite 24
Malvern, PA, 19355
Malvern, PA, 19355